ARCHIVES

NCI Budget of $1.4 Billion Seems Assured, Barring GRH Cut, Veto; Organ Systems Renewal Confirmed

This article is from The Cancer Letter archive.

Vol. 12 No. 40 | October 17, 1986

Download PDF Visit The Full Archive

Related Articles

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

May 27, 2011

In Brief: NIH gives Advisors $50 Raise, Effective April 1, No Fooling

March 12, 1999

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994

In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer

December 16, 1994